Jeffrey Himmelreich - Jan 24, 2024 Form 4 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role
Head of Finance
Signature
Jeffrey Himmelreich
Stock symbol
MAIA
Transactions as of
Jan 24, 2024
Transactions value $
$0
Form type
4
Date filed
1/26/2024, 04:07 PM
Previous filing
Nov 20, 2023
Next filing
Apr 30, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MAIA Stock Options Award $0 +10K $0.00 10K Jan 24, 2024 Common Stock 10K $1.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options, granted on January 24, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of the grant and the remaining options to vest ratably monthly thereafter for 36 months.